Back to Search
Start Over
Targeting hyperactive TGFBR2 for treating MYOCD deficient lung cancer.
- Source :
- Theranostics; 2021, Vol. 11 Issue 13, p6592-6606, 15p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 18387640
- Volume :
- 11
- Issue :
- 13
- Database :
- Complementary Index
- Journal :
- Theranostics
- Publication Type :
- Academic Journal
- Accession number :
- 177069440
- Full Text :
- https://doi.org/10.7150/thno.59816